Project Description

FORCE Webinar:

First Light Diagnostics
The Solution for Hospital-Acquired Infections

RSVP:

Please include area code

Please join First Light CEO, David Macdonald, as he hosts a webinar  to discuss their new rapid antimicrobial susceptibility test, its applications during the current crisis, and beyond.

Date & Time:

July 15, 10:00 AM EDT
Webinar: Details provided upon RSVP approval

About the Event:

With the rise in ventilator use due to COVID-19, Ventilator Acquired Pneumonia (VAP) is also on the rise. An infection can occur if germs enter through the tube and get into the patient’s lungs. While prevention measures should be taken to lower the number of infections, treating infected patients fast is critical. That’s where First Light comes in.  Their MultiPath™ technology provides Antimicrobial Susceptibility Testing which allows doctors to treat VAP patients quickly with targeted antibiotics.

In addition to saving lives, First Light Diagnostics is combating antibiotic resistance by shortening targeted therapy decisions to be made in hours versus days. This is a game changer that will reduce healthcare cost and the disturbing trend in antimicrobial resistance.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.